Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May:238:109027.
doi: 10.1016/j.clim.2022.109027. Epub 2022 May 2.

SARS-CoV-2/COVID-19 and its relationship with NOD2 and ubiquitination

Affiliations
Review

SARS-CoV-2/COVID-19 and its relationship with NOD2 and ubiquitination

Edgardo Guzman Rivera et al. Clin Immunol. 2022 May.

Abstract

COVID-19 infection activates the immune system to cause autoimmune and autoinflammatory diseases. We provide a comprehensive review of the relationship between SARS-CoV-2, NOD2 and ubiquitination. COVID-19 infection partly results from host inborn errors and genetic factors and can lead to autoinflammatory disease. The interaction between defective NOD2 and viral infection may trigger NOD2-associated disease. SARS-CoV-2 can alter UBA1 and abnormal ubiquitination leading to VEXAS syndrome. Both NOD2 and ubiquitination play important roles in controlling inflammatory process. Receptor interacting protein kinase 2 is a key component of the NOD2 activation pathway and becomes ubiquitinated to recruit downstream effector proteins. NOD2 mutations result in loss of ubiquitin binding and increase ligand-stimulated NOD2 signaling. During viral infection, mutations of either NOD2 or UBA1 genes or in combination can facilitate autoinflammatory disease. COVID-19 infection can cause autoinflammatory disease. There are reciprocal interactions between SARS-CoV-2, NOD2 and ubiquitination.

Keywords: Autoinflammatory disease; COVID-19; NOD2; SARS-CoV-2; Ubiquitination; VEXAS syndrome; Yao syndrome.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest.

Figures

Fig. 1
Fig. 1
Clinical phenotype and dermatopathological findings. (A) Normal ear (B) Auricular inflammation (C) Right thumb swelling (D) Lower extremity purpuric papules (E) Perivascular infiltrate with lymphocytes and extravasated erythrocytes (direct immunofluorescence staining Declaration of Competing Interest
Fig. 2
Fig. 2
Schematic representation of the interaction between SARS-CoV2, NOD2 and ubiquitination. NOD2, Nucleotide-binding oligomerization domain-containing protein 2; IRF3, Interferon regulatory factor 3; IFN-β, Interferon beta; RIPK2, Receptor interacting protein kinase 2; NFkB1, Nuclear factor kappa B; IL-1, Interleukin 1; UBA1, Ubiquitin-like modifier activating enzyme 1; IL-8, Interleukin 8; VEXAS, Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic. .

Similar articles

Cited by

References

    1. Lee A.C., Chakladar J., Li W.T., Chen C., Chang E.Y., Wang-Rodriguez J., et al. Tobacco, but not nicotine and flavor-less electronic cigarettes, induces ACE2 and immune dysregulation. Int. J. Mol. Sci. 2020;21(15):5513. - PMC - PubMed
    1. Bowie A.G., Unterholzner L. Viral evasion and subversion of pattern-recognition receptor signalling. Nat. Rev. Immunol. 2008;8(12):911–922. - PMC - PubMed
    1. Zhang Q., Bastard P., Liu Z., Le Pen J., Moncada-Velez M., Chen J., et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020;370(6515):eabd4570. - PMC - PubMed
    1. Initiative C.-H.G. Mapping the human genetic architecture of COVID-19. Nature. 2021;600(7889):472–477. - PMC - PubMed
    1. Qin C., Zhou L., Hu Z., Yang S., Zhang S., Chen M., et al. Clinical characteristics and outcomes of COVID-19 patients with a history of stroke in Wuhan, China. Stroke. 2020;51(7):2219–2223. - PMC - PubMed